Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

metastatic disease

  • You have access
    Outcomes of Intramedullary Nail Fixation for Metastatic Disease: Impending and Pathologic Fractures
    AARON R. OWEN, MASON E. UVODICH, VIVEK SOMASUNDARAM, BRANDON J. YUAN, PETER S. ROSE and MATTHEW T. HOUDEK
    Anticancer Research February 2022, 42 (2) 919-922; DOI: https://doi.org/10.21873/anticanres.15550
  • You have access
    Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma
    AARON HAAG, DEANNA HUFFMAN, CHELSEA PETERSON, KARTHIK SHANKAR, LYNNA ALNIMER, YAZAN SAMHOURI and LARISA GREENBERG
    Anticancer Research May 2021, 41 (5) 2485-2488; DOI: https://doi.org/10.21873/anticanres.15025
  • You have access
    Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool
    HEINKE C. HANSEN, STEFAN JANSSEN, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research April 2019, 39 (4) 2091-2095; DOI: https://doi.org/10.21873/anticanres.13321
  • You have access
    Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study
    WOLFGANG SCHULTZE-SEEMANN, HOLGER SCHULZ, BARBARA TSCHECHNE and MANUEL HÄCKL
    Anticancer Research February 2019, 39 (2) 875-882; DOI: https://doi.org/10.21873/anticanres.13188
  • You have access
    Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study
    LUÍS MANSO, ANDRÉS GARCÍA PALOMO, RAMÓN PÉREZ CARRIÓN, JAVIER CASSINELLO, ISABEL GALLEGOS SANCHO, IGNACIO CHACÓN LÓPEZ-MUÑIZ, CLARA OLIER, ANTONIO FERNÁNDEZ-ARAMBURO, CRISTINA LLORCA, XAVIER GONZÁLEZ, ROSA LLORENTE, DOLORES TORREGROSA, IÑAKI ÁLVAREZ, ELENA GÁLVE, CORALIA BUENO, ISABEL GARAU, MARÍA JOSÉ GARCÍA, SANTIAGO GONZÁLEZ-SANTIAGO, ANA ISABEL BALLESTEROS, ESPERANZA BLANCO, ANTONIO GALÁN, SONIA GONZÁLEZ, ANTONIA PERELLÓ, HERNÁN CORTÉS-FUNES and CRISTINA GRÁVALOS
    Anticancer Research December 2015, 35 (12) 6941-6950;
  • You have access
    Soft Tissue Limb and Trunk Sarcomas: Diagnosis, Treatment and Follow-up
    MARCO RASTRELLI, SAVERIA TROPEA, UMBERTO BASSO, ANNA ROMA, MARCO MARUZZO and CARLO RICCARDO ROSSI
    Anticancer Research October 2014, 34 (10) 5251-5262;
  • You have access
    Hypertension as a Predictive Marker for Bevacizumab in Metastatic Breast Cancer: Results from a Retrospective Matched-pair Analysis
    SIMON PETER GAMPENRIEDER, FRANZ ROMEDER, CLAUDIA MUß, MAGDALENA PIRCHER, SIGRUN RESSLER, GABRIEL RINNERTHALER, RUPERT BARTSCH, CLAUDIA SATTLBERGER, BRIGITTE MLINERITSCH and RICHARD GREIL
    Anticancer Research January 2014, 34 (1) 227-233;
  • You have access
    Response to Chemotherapy in Metastatic Colorectal Cancer After Exposure to Oxaliplatin in the Adjuvant Setting
    LOUIS-CHARLES MOREAU, RAGHU RAJAN, MICHAEL P. THIRLWELL and THIERRY ALCINDOR
    Anticancer Research April 2013, 33 (4) 1765-1768;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire